Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer
Titel:
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer
Auteur:
Garon, Edward B. Siegfried, Jill M. Stabile, Laura P. Young, Patricia A. Marquez-Garban, Diana C. Park, David J. Patel, Ravi Hu, Eddie H. Sadeghi, Saeed Parikh, Rupesh J. Reckamp, Karen L. Adams, Brad Elashoff, Robert M. Elashoff, David Grogan, Tristan Wang, He-Jing Dacic, Sanja Brennan, Meghan Valdes, Yacgley Davenport, Simon Dubinett, Steven M. Press, Michael F. Slamon, Dennis J. Pietras, Richard J.